Question 1

Why tag at the endogenous locus rather than overexpress?

Accepted Answer

Because overexpressed tagged protein sits at non-physiological levels and often escapes complete removal, leaving residual activity that masks the phenotype. Endogenous tagging keeps expression under native control and makes depletion meaningful. It demands more editing effort and careful verification that every allele carries the tag, which is worth the additional time.

Question 2

How is baseline leakiness measured?

Accepted Answer

By comparing the tagged line against the untagged parent without any inducer, using a quantitative protein measurement. Many degron systems remove a noticeable fraction constitutively, so a tagged line may already be partially depleted before an experiment starts. Reporting this baseline is essential for interpreting anything observed afterwards.

Question 3

Does tag position matter?

Accepted Answer

Considerably. Amino-terminal and carboxy-terminal placement give different removal efficiency and different risk of disturbing folding, localisation or interactions. Testing both where feasible, and confirming that the tagged protein still performs its known function before induction, is the standard approach rather than an optional refinement.

Question 4

How should depletion be reported?

Accepted Answer

As a time-course with a quantitative readout, showing both the rate and the residual fraction remaining at plateau. Many systems never reach complete removal, and a persistent few percent can sustain function. Stating the plateau level explicitly prevents a partial depletion from being read as a full loss.

Question 5

What rescue controls does a phenotype claim need?

Accepted Answer

Re-expression of an untagged copy resistant to the removal system, restoring the phenotype toward normal. Alongside that, an inducer-only condition in untagged cells rules out inducer toxicity, and a tagged uninduced condition rules out the tag itself. Together these separate protein loss from the machinery used to achieve it.

Question 6

Which system suits a given organism?

Accepted Answer

Availability differs sharply. Auxin-based systems need the plant ligase component expressed, which works well in several models but requires extra engineering. Ligand-controlled destabilising domains avoid that at the cost of different kinetics. Checking what has been validated in the specific organism before committing saves considerable early effort.

Question 7

Is reversibility worth building in?

Accepted Answer

Frequently, yes. Washing out the inducer and following recovery distinguishes an acute requirement from irreversible damage, and provides a strong internal control. Recovery is rarely instantaneous, so the resynthesis time-course should be measured rather than assumed when designing experiments that depend on restoring the protein.

Biotechnology

Biotechnology

Research Frontiers in Protein Degradation Tagging Systems